ArticleMedComm2023

CRISPR-Cas13d effectively targets SARS-CoV-2 variants, including Delta and Omicron, and inhibits viral infection.

Zongzhi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.